DIVISION OF PULMONARY & CRITICAL CARE MEDICINE | OHSU
Transforming Pulmonary and Critical Illness Through Clinical Discovery
Directed by Dr. Akram Khan, MBBS, PRISM tests new treatments and therapies for serious lung and critical illnesses at OHSU:
Inpatient ICU Trials: Urgent hospital studies for ARDS, sepsis, and life-threatening respiratory failure.
Outpatient Clinic Trials: Long-term clinic studies for COPD, chronic lung disease, and lung recovery.
Research
Phase III study evaluating an intravenous administration of mesenchymal stem cell-derived extracellular vesicles vs. placebo for moderate to severe ARDS.
Phase IV study assessing Cystatin C and pharmacokinetic profiles of meropenem and cefepime in critically ill adults with antimicrobial-resistant infections.
Comparing the use of a hyperangulated video laryngoscope blade versus a standard geometry video laryngoscope blade during emergency intubation.
Observational study collecting biospecimens via bronchoscopy in ARDS patients to evaluate early onset markers and outcomes.